| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
B of Human 25-Hydroxyvitamin D3 1
-Hydroxylase Promoter
Orthopedic Department (R.E., M.J., M.U., D.S., J.M.-W., F.J.), University of Wuerzburg, Wuerzburg, Germany; and Institute of Experimental Genetics (J.A.), GSF-National Research Center for Environment and Health, Neuherberg, Germany
Address all correspondence and requests for reprints to: Franz Jakob, M.D., Experimental and Clinical Osteology, Orthopedic Department, University of Wuerzburg, Brettreichstrasse 11, D-97074 Wuerzburg, Germany. E-mail: f-jakob. klh{at}mail.uni-wuerzburg.de.
1,25-(OH)2 vitamin D3 is important for calcium homeostasis and cell differentiation. The key enzyme for the activation of liver-derived 25(OH) vitamin D3 is 25-hydroxyvitamin D3 1
-hydroxylase. It is expressed mainly in the kidney but also in peripheral tissues. A 1413-bp fragment of the 1
-hydroxylase promoter was cloned into luciferase vectors pGL2basic and pGL3basic. Sequence analyses revealed four base exchanges and three base deletions compared with the published sequence which were identically found in five control persons. In silico promoter analyses revealed 17 putative nuclear factor (NF)
B sites, 10 of which were found to bind NF
B in EMSA experiments. Cotransfection of NF
B p50 and p65 subunits resulted in dramatic reduction of the promoter activity of the full-length construct as well as a series of 5'-deletion constructs. Deletion of the farmost 3'-situated NF
B-responsive element almost abolished NF
B responsiveness. Treatment of human embryonic kidney 293 cells with sulfasalazine, a NF
B inhibitor, resulted in enhanced 1
-hydroxylase mRNA production. Down-regulation of 1
-hydroxylase promoter through NF
B signaling may contribute to the pathogenesis of inflammation-associated osteopenia/osteoporosis.
This article has been cited by other articles:
![]() |
M. Eisenhut Effect of Vitamin D on Tuberculosis and HIV Replication Depends on Conversion to Calcitriol and Concentration Am. J. Respir. Crit. Care Med., October 15, 2009; 180(8): 795 - 795. [Full Text] [PDF] |
||||
![]() |
N. Liu, L. Nguyen, R. F. Chun, V. Lagishetty, S. Ren, S. Wu, B. Hollis, H. F. DeLuca, J. S. Adams, and M. Hewison Altered Endocrine and Autocrine Metabolism of Vitamin D in a Mouse Model of Gastrointestinal Inflammation Endocrinology, October 1, 2008; 149(10): 4799 - 4808. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Miller, G. E. Hicks, M. D. Shardell, A. R. Cappola, W. G. Hawkes, J. A. Yu-Yahiro, A. Keegan, and J. Magaziner Association of Serum Vitamin D Levels With Inflammatory Response Following Hip Fracture: The Baltimore Hip Studies J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1402 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Turunen, T. W. Dunlop, C. Carlberg, and S. Vaisanen Selective use of multiple vitamin D response elements underlies the 1 {alpha} ,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene Nucleic Acids Res., April 10, 2007; (2007) gkm179v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Driel, M. Koedam, C. J. Buurman, M. Hewison, H. Chiba, A. G. Uitterlinden, H. A. P. Pols, and J. P. T. M. van Leeuwen Evidence for auto/paracrine actions of vitamin D in bone: 1{alpha}-hydroxylase expression and activity in human bone cells FASEB J, November 1, 2006; 20(13): 2417 - 2419. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohnesorg, B. Keller, M. H. de Angelis, and J. Adamski Transcriptional regulation of human and murine 17{beta}-hydroxysteroid dehydrogenase type-7 confers its participation in cholesterol biosynthesis. J. Mol. Endocrinol., August 1, 2006; 37(1): 185 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P Dwivedi, P. H Anderson, J. L Omdahl, H L. Grimes, H. A Morris, and B. K May Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells Endocr. Relat. Cancer, June 1, 2005; 12(2): 351 - 365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |